Glaxo Group Ltd

General

Total Cases64

Active Cases--

Patents937

CourtsD. Delaware D. New Jersey S.D. New York

TypeOperating Company

Elite Ratings

DCT

glaxosmithkline

Ratings

Experience

Grade

Trend

DCT

L4

A

PTAB

L5

E

CAFC

L3

E

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
04/13/22	Drit LP v. Glaxo Group Ltd 1:21-CV-00844 ( D. DE )	Letter to Prothonotary from Clerk USDC/DE regarding Remand Order. (ntl) (Entered: 04/13/2022)
04/13/22	Drit LP v. Glaxo Group Ltd 1:21-CV-00844 ( D. DE )	CASE CLOSED (ntl) (Entered: 04/13/2022)
04/13/22	Drit LP v. Glaxo Group Ltd 1:21-CV-00844 ( D. DE )	CASE CLOSED (ntl) (Entered: 04/13/2022)
03/29/22	Drit LP v. Glaxo Group Ltd 1:21-CV-00844 ( D. DE )	MEMORANDUM ORDER: IT IS HEREBY ORDERED that GSK`s objections (D.I. 22) are OVERRULED, the Report (D.I. 21) is ADOPTED, and the pending portion of DRIT`s motion to remand (D.I. 4) is GRANTED. IT IS FURTHER ORDERED that the pending motion to dismiss (D.I. 12) is DENIED AS MOOT. The Clerk of Court is directed to CLOSE this case. Signed by Judge Leonard P. Stark on 3/29/22. (ntl) (Entered: 03/29/2022) MEMORANDUM ORDER: IT IS HEREBY ORDERED that GSK`s objections (D.I. 22) are OVERRULED, the Report (D.I. 21) is ADOPTED, and the pending portion of DRIT`s motion to remand (D.I. 4) is GRANTED. IT IS FURTHER ORDERED that the pending motion to dismiss (D.I. 12) is DENIED AS MOOT. The Clerk of Court is directed to CLOSE this case. Signed by Judge Leonard P. Stark on 3/29/22. (ntl) (Entered: 03/29/2022)
03/29/22	Drit LP v. Glaxo Group Ltd 1:21-CV-00844 ( D. DE )	Case Reassigned to Judge Leonard P. Stark of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (LPS) after the case number on all documents filed. (ntl) (Entered: 03/29/2022)
03/18/22	Drit LP v. Glaxo Group Ltd 1:21-CV-00844 ( D. DE )	RESPONSE TO OBJECTIONS by DRIT LP re 22 Objection to Report and Recommendations . (Attachments: # 1 Exhibit A)(Shandler, Chad) (Entered: 03/18/2022)
03/08/22	Drit LP v. Glaxo Group Ltd 1:21-CV-00844 ( D. DE )	NOTICE of Lodging by Glaxo Group Limited, Human Genome Sciences, Inc. re 22 Objection to Report and Recommendations (Rovner, Philip) (Entered: 03/08/2022)
03/04/22	Drit LP v. Glaxo Group Ltd 1:21-CV-00844 ( D. DE )	OBJECTION to 21 Report and Recommendations by Glaxo Group Limited, Human Genome Sciences, Inc.. (Attachments: # 1 Certification)(Rovner, Philip) (Entered: 03/04/2022)
02/18/22	Drit LP v. Glaxo Group Ltd 1:21-CV-00844 ( D. DE )	REPORT AND RECOMMENDATIONS regarding D.I. 4 MOTION to Remand filed by DRIT LP. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 3/4/2022. Signed by Judge Christopher J. Burke on 2/18/2022. (dlb) (Entered: 02/18/2022) REPORT AND RECOMMENDATIONS regarding D.I. 4 MOTION to Remand filed by DRIT LP. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 3/4/2022. Signed by Judge Christopher J. Burke on 2/18/2022. (dlb) (Entered: 02/18/2022)
12/10/21	Drit LP v. Glaxo Group Ltd 1:21-CV-00844 ( D. DE )	ORAL ORDER: The Court, having reviewed the parties` December 10, 2021 letter, (D.I. 19), hereby ORDERS that it will not set a schedule in this action. Ordered by Judge Christopher J. Burke on 12/10/2021. (mlc) (Entered: 12/10/2021)